Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- CZK 112.51T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | CZK 221.8B | CZK 1,467.11 | 5.25% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | CZK 183.9B | CZK 2,652.48 | 2.33% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | CZK 105B | CZK 1,865.24 | 3.53% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | CZK 183.9B | CZK 2,817.08 | 1.65% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | CZK 190.7B | CZK 6,822.41 | 0.61% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | CZK 158.7B | CZK 1,139.13 | 0.78% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | CZK 102.3B | CZK 614.41 | 2.52% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | CZK 132.8B | CZK 6,641.14 | 1.68% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | CZK 214.3B | CZK 2,256.47 | 8.21% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | CZK 174.7B | CZK 1,039.32 | 2.87% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | CZK 100.9B | CZK 921.28 | 1.42% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | CZK 336.4B | CZK 1,726.86 | 1.15% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | CZK 106.2B | CZK 302.65 | 1.98% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | CZK 107.5B | CZK 617.63 | 0.23% down | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | CZK 133.7B | CZK 2,048.40 | 0.22% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | CZK 106.8B | CZK 1,112.78 | 2.04% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | CZK 144.1B | CZK 2,124.76 | 0.76% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | CZK 111.5B | CZK 1,334.07 | 0.57% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | CZK 204.5B | CZK 8,802.91 | 6.16% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | CZK 351.4B | CZK 5,474.78 | 2.32% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | CZK 165B | CZK 1,507.57 | 3.21% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | CZK 135.7B | CZK 959.74 | 0.43% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | CZK 116.8B | CZK 2,767.62 | 0.90% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | CZK 265B | CZK 1,368.19 | 5.20% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | CZK 88.6B | CZK 647.31 | 0.88% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | CZK 297.5B | CZK 595.29 | 3.60% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | CZK 583.6B | CZK 2,660.37 | 1.79% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | CZK 623.2B | CZK 860.04 | 0.05% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | CZK 156.2B | CZK 2,968.91 | 1.76% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | CZK 70.5B | CZK 363.67 | 1.55% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | CZK 165.6B | CZK 2,107.53 | 0.32% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | CZK 186.6B | CZK 233.29 | 1.64% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | CZK 162.8B | CZK 1,860.23 | 1.93% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | CZK 393.8B | CZK 6,003.83 | 0.41% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | CZK 548B | CZK 12,867.03 | 0.90% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | CZK 773.2B | CZK 1,903.02 | 2.55% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | CZK 444.8B | CZK 3,320.90 | 4.54% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | CZK 142B | CZK 3,495.18 | 0.31% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | CZK 169.1B | CZK 485.26 | 3.36% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | CZK 518.4B | CZK 452.14 | 0.54% down | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | CZK 277.6B | CZK 332.99 | 1.28% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | CZK 1.09T | CZK 937.84 | 1.01% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | CZK 3.55T | CZK 623.08 | 1.55% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | CZK 2.71T | CZK 1,325.02 | 2.84% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | CZK 877.3B | CZK 1,525.80 | 0.06% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | CZK 2.17T | CZK 21,020.19 | 1.27% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | CZK 3.03T | CZK 11,954.31 | 0.67% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | CZK 700.4B | CZK 1,135.90 | 1.66% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | CZK 1.02T | CZK 8,961.84 | 2.44% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | CZK 4.03T | CZK 2,326.93 | 0.03% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | CZK 7.55T | CZK 3,061.60 | 3.93% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | CZK 11.23T | CZK 6,354.05 | 2.38% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | CZK 128.1B | CZK 188.17 | 1.91% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | CZK 3.87T | CZK 877.49 | 3.01% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | CZK 27.4T | CZK 30,761.60 | 2.24% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | CZK 2.17T | CZK 1,081.22 | 1.22% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | CZK 14.62T | CZK 6,071.18 | 2.00% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | CZK 2.52T | CZK 1,048.21 | 0.79% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | CZK 6.52T | CZK 3,452.83 | 2.39% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | CZK 6.16T | CZK 3,974.55 | 1.90% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | CZK 1.51T | CZK 472.26 | 1.83% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2290 CZK).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of CZK 112.51T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.